MedTrace Logo

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin

NCT01387048 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-07-08

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of Skinoren® 15% gel compared to no therapy on the maintenance of clinical therapy success in subjects with mild to moderate acne vulgaris previously treated for 3 months by a monotherapy of this substance and to assess the effect of Skinoren® 15% gel, compared to Differin® 0.1% gel on the efficacy and safety during a 9-month long-term treatment period.

Conditions

  • Acne Vulgaris

Interventions

DRUG

skinoren

gel 15%, twice daily, 36 weeks

DRUG

differin

0.1% gel, once daily in the evening

DRUG

skinoren

12 weeks treatment, the following 24 months only observation

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • University of Magdeburg

    lead OTHER

Principal Investigators

  • Anja Thielitz, Dr. med. · unfillated

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-08-31
Completion
2012-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387048 on ClinicalTrials.gov